JULI DEGRAVE: Open Payments
NPI 1790297331 · KENOSHA, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,597 in 151 payments from 21 companies in 2025. Trend: 2023 $2,675 · 2024 $3,135 · 2025 $3,597
Food & beverage: $3,597
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $484 |
| Axsome Therapeutics, Inc. | 20 | $450 |
| Aimmune Therapeutics, Inc. | 10 | $429 |
| Novo Nordisk Inc | 13 | $428 |
| Lilly USA, LLC | 16 | $340 |
| Dexcom, Inc. | 10 | $270 |
| Phathom Pharmaceuticals, Inc. | 14 | $227 |
| Boston Scientific Corporation | 2 | $180 |
| E.R. Squibb & Sons, L.L.C. | 16 | $175 |
| ABBVIE INC. | 9 | $161 |
Products named: Auvelity, ZENPEP, Dexcom G6 Transmitter, VOQUEZNA, AIRSUPRA, WATCHMAN Access System, ELIQUIS, MOUNJARO.
Industry payments across WI — which companies pay providers there.
